Kercheville Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-19,797
| Closed | -$866K | – | 95 |
|
|
2022
Q3 | $866K | Sell |
19,797
-508
| -3% | -$22.2K | 0.89% | 33 |
|
|
2022
Q2 | $1.07M | Buy |
20,305
+79
| +0.4% | +$4.14K | 0.7% | 33 |
|
|
2022
Q1 | $1.05M | Sell |
20,226
-646
| -3% | -$33.4K | 0.5% | 44 |
|
|
2021
Q4 | $1.23M | Sell |
20,872
-5,828
| -22% | -$344K | 0.54% | 41 |
|
|
2021
Q3 | $1.15M | Buy |
26,700
+7,200
| +37% | +$310K | 0.54% | 41 |
|
|
2021
Q2 | $764K | Buy |
19,500
+520
| +3% | +$20.4K | 0.35% | 64 |
|
|
2021
Q1 | $687K | Sell |
18,980
-27,488
| -59% | -$995K | 0.34% | 62 |
|
|
2020
Q4 | $1.7M | Buy |
+46,468
| New | +$1.7M | 0.93% | 30 |
|